A sanguineous pleuro pericardial effusion in a patient recently treated with Dabigatran

Heart & Lung : the Journal of Critical Care
Mokhtar AbdallahLouis Sasso

Abstract

Dabigatran, a direct thrombin inhibitor, is one of the new oral anticoagulants. As more patients receive treatment with Dabigatran, and as the clinical indications for Dabigatran use expand, reporting serious adverse effects is fundamental to future safety assessment. Although patients taking Dabigatran had fewer life-threatening bleeds when compared to Coumadin, those events continue to be reported. We describe, in the same patient, a sanguineous pleuro pericardial effusion that was diagnosed incidentally on a pre-ablation cardiac CT angiography. The diagnosis was made approximately two months after initiating Dabigatran treatment for non-valvular atrial fibrillation in a 63-year-old patient.

References

Nov 1, 1952·A.M.A. Archives of Internal Medicine·M W ANDERSONJ E EDWARDS
Dec 8, 2009·The New England Journal of Medicine·Sam SchulmanUNKNOWN RE-COVER Study Group
Jan 1, 2010·The New England Journal of Medicine·Donald Stuart Houston, Ryan Zarychanski
Mar 6, 2012·The American Journal of Geriatric Pharmacotherapy·Ennie L Cano, Marta A Miyares
Apr 11, 2012·Pharmacotherapy·Cassie A BartonRay E Keller
Dec 18, 2013·Circulation·Sam SchulmanUNKNOWN RE-COVER II Trial Investigators
Nov 29, 2014·Expert Review of Cardiovascular Therapy·Sophie Vanden DaelenErik Vandermeulen
Jul 23, 2016·ACS Applied Materials & Interfaces·Imanol Landa-MedranoTeófilo Rojo

❮ Previous
Next ❯

Citations

Jul 28, 2016·The Clinical Respiratory Journal·Thanasis VoulgarisMarios Froudarakis
May 20, 2020·Arquivos brasileiros de cardiologia·Adem AdarFahri Cakan
Sep 25, 2017·Drug Safety - Case Reports·Jing HuangQunli Ding
May 10, 2017·Case Reports in Cardiology·Sijan BasnetDilli Ram Poudel
Mar 6, 2016·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Claudia StöllbergerJosef Finsterer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.